Stay updated on Sitravatinib and Tislelizumab in Uveal Melanoma Clinical Trial
Sign up to get notified when there's something new on the Sitravatinib and Tislelizumab in Uveal Melanoma Clinical Trial page.

Latest updates to the Sitravatinib and Tislelizumab in Uveal Melanoma Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision updated from v3.6.2 to v3.6.3 to reflect the latest page version. This indicates an incremental update to the page's version metadata rather than a content change.SummaryDifference0.0%

- Check18 days agoChange DetectedRevision label updated from v3.6.0 to v3.6.2. This indicates a newer build of the page and does not change the study content.SummaryDifference0.0%

- Check33 days agoChange DetectedThe page now indicates that no participants are being recruited ('No longer looking for participants'). New navigation/help items were added (How to Read a Study Record, Common Questions, How to Join a Study), the Intervention/Treatment header formatting was adjusted, and the revision version was updated to v3.6.0.SummaryDifference0.4%

- Check40 days agoChange DetectedResults for SITISVEAL (NCT05542342) were posted on 2026-06-01, updating the study record with the results submission date and extended follow-up and imaging schedules after treatment initiation. The update also references the predefined outcomes (ORR, PFS, OS) used to measure treatment efficacy.SummaryDifference8%

- Check61 days agoChange DetectedThe page's revision level updated from v3.5.3 to v3.5.4, signaling a small internal update to the page. No user-visible content or trial data changes are introduced by this revision.SummaryDifference0.1%

- Check68 days agoChange DetectedResult status on the study page now displays 'Results Submitted' instead of 'No Results Posted'. This updates the study record to show that the trial’s results have been submitted for reporting.SummaryDifference0.1%

Stay in the know with updates to Sitravatinib and Tislelizumab in Uveal Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sitravatinib and Tislelizumab in Uveal Melanoma Clinical Trial page.